Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Efficacy and Safety of the Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Benazepril

This study will evaluate efficacy and safety data for benazepril/hydrochlorothiazide in adult Chinese patients with mild to moderate essential hypertension. Patients whose blood pressure is not adequately controlled with benazepril monotherapy during a 4 week run-in period will be randomly allocated to double blind treatment over 8 weeks with either a combination of benazepril/hydrochlorothiazide per day or continuation of benazepril per day.

Inclusion Criteria:

• Male or female patients, age 18 or older
• Given informed consent
• Diagnosed as having mild to moderate essential hypertension

Exclusion Criteria:

• Severe hypertension
• Significant preexisting cardiovascular and cerebrovascular disease
• Diabetes mellitus type 1 or poorly controlled diabetes mellitus type II
• Advanced renal impairment

Other protocol-defined inclusion/exclusion criteria may apply.